Difference between revisions of "The Impact of a Decision Support Tool Linked to an Electronic Medical Record on Glycemic Control in People with Type 2 Diabetes"

From Clinfowiki
Jump to: navigation, search
(Methods)
Line 10: Line 10:
  
 
=Methods=  
 
=Methods=  
A total of 875 patients participated in this study for 84 months. A total of 342 patients were seen by physicians who had access to clinical decision support and 533 patients were managed by physicians with no clinical decision support. The study looked at the effects of glycosylated hemoglobin (HbA1c).<refname="Decision Support tool linked to EMR on glycemic control with Type 2 diabetes">the Impact of a Decision Support Tool LInked to an Electronic Medical Record on Glycemic Control in People with type 2 Diabetes.http://www-ncbi-nlm-nih-gov.ezproxyhost.library.tmc.edu/pmc/articles/PMC3869133/
+
A total of 875 patients participated in this study for 84 months. A total of 342 patients were seen by physicians who had access to clinical decision support and 533 patients were managed by physicians with no clinical decision support. The study looked at the effects of glycosylated hemoglobin (HbA1c).<refname="http://www-ncbi-nlm-nih-gov.ezproxyhost.library.tmc.edu/pmc/articles/PMC3869133/
 
</ref>
 
</ref>
  

Revision as of 22:26, 2 March 2015

The authors wanted to compare the glycemic control of patients with Type 2 Diabetes who were treated by physicians with access to decision support and physicians with out access to decision support.



Aim

To compare the outcomes of glycemic control and glycemic burden of patients with Type 2 diabetes treated by a general practioners with access to clinical decision support as oppose to practioners with no access to clinical decision support.


Methods

A total of 875 patients participated in this study for 84 months. A total of 342 patients were seen by physicians who had access to clinical decision support and 533 patients were managed by physicians with no clinical decision support. The study looked at the effects of glycosylated hemoglobin (HbA1c).<refname="http://www-ncbi-nlm-nih-gov.ezproxyhost.library.tmc.edu/pmc/articles/PMC3869133/ </ref>

Results

The study showed no difference for the 1st year but the 2nd year there was a significant difference in glycemic control.



Conclusion

The authors concluded that the use of clinical decision support did help the physicians with their patients glycemic control.



References